127 related articles for article (PubMed ID: 11314758)
1. 99Tc(m) labelled HL91 versus computed tomography and biopsy for the visualization of tumour recurrence of squamous head and neck carcinoma.
Van De Wiele C; Versijpt J; Dierckx RA; Moerman M; Lemmerling M; D'Asseler Y; Vermeersch H
Nucl Med Commun; 2001 Mar; 22(3):269-75. PubMed ID: 11314758
[TBL] [Abstract][Full Text] [Related]
2. SPECT-CT for topographic mapping of sentinel lymph nodes prior to gamma probe-guided biopsy in head and neck squamous cell carcinoma.
Wagner A; Schicho K; Glaser C; Zettinig G; Yerit K; Lang S; Klug C; Leitha T
J Craniomaxillofac Surg; 2004 Dec; 32(6):343-9. PubMed ID: 15555515
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG.
Cook GJ; Houston S; Barrington SF; Fogelman I
J Nucl Med; 1998 Jan; 39(1):99-103. PubMed ID: 9443745
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-MIBI in primary and recurrent head and neck tumors: contribution of bone SPECT image fusion.
Leitha T; Glaser C; Pruckmayer M; Rasse M; Millesi W; Lang S; Nasel C; Backfrieder W; Kainberger F
J Nucl Med; 1998 Jul; 39(7):1166-71. PubMed ID: 9669388
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-labelled HL91 and technetium-99m-labelled MIBI SPECT imaging for the detection of ischaemic viable myocardium: a preliminary study.
Liu M; Ma Z; Guo X; Zhu J; Su J
Clin Physiol Funct Imaging; 2012 Jan; 32(1):25-32. PubMed ID: 22152075
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary study on the value of 99Tc(m)-HL91 imaging in predicting sensitivity to radiotherapy in patients with nasopharyngeal carcinoma].
Liu S; Xue Y; Zhang H; Liang JG; Lu XP; Liu XG; Chen SX; Jing NY
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):369-72. PubMed ID: 17892134
[TBL] [Abstract][Full Text] [Related]
7. Detection of ischemic myocardium with a new hypoxic tissue targeting tracer 99Tc(m)-HL91.
Lü J; Liu G; Fang Y; Wu H
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(3):281-3, 291. PubMed ID: 16961269
[TBL] [Abstract][Full Text] [Related]
8. Phase 1 study to identify tumour hypoxia in patients with head and neck cancer using technetium-99m BRU 59-21.
Hoebers FJ; Janssen HL; Olmos AV; Sprong D; Nunn AD; Balm AJ; Hoefnagel CA; Begg AC; Haustermans KM
Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1206-11. PubMed ID: 12192567
[TBL] [Abstract][Full Text] [Related]
9. [Correlations of 99 Tc m-HL91 SPECT hypoxia imaging with HIF-1alpha and VEGF expression in non-small cell lung cancer].
Li L; Hu M; Yu JM; Yang GR; Guo HB; Gao Y
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):669-73. PubMed ID: 20021862
[TBL] [Abstract][Full Text] [Related]
10. Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: a pilot study.
Stokkel MP; ten Broek FW; van Rijk PP
Eur J Nucl Med; 1999 May; 26(5):499-503. PubMed ID: 10382094
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of only 18F-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma.
Lee SH; Huh SH; Jin SM; Rho YS; Yoon DY; Park CH
Otolaryngol Head Neck Surg; 2012 Oct; 147(4):692-8. PubMed ID: 22535915
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of 9mTc-HL91 SPECT hypoxia imaging in patients with advanced NSCLC].
Li L; Yu JM; Sun XD; Zhu H; Yue JB; Sun CJ; Yang GR
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):127-30. PubMed ID: 17645850
[TBL] [Abstract][Full Text] [Related]
13. Scintigraphy for interpretation of malignant tumours of the head and neck: comparison of technetium-99m-hexakis-2-methoxyisobutylisonitrile (Tc-MIBI) and thallium-201-chloride (Tl-201).
Sato T; Kawabata Y; Kobayashi Y; Suenaga S; Indo H; Kawano K; Iwashita Y; Morita Y; Majima HJ
Dentomaxillofac Radiol; 2005 Sep; 34(5):268-73. PubMed ID: 16120875
[TBL] [Abstract][Full Text] [Related]
14. Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography.
van de Wiele C; Lahorte C; Vermeersch H; Loose D; Mervillie K; Steinmetz ND; Vanderheyden JL; Cuvelier CA; Slegers G; Dierck RA
J Clin Oncol; 2003 Sep; 21(18):3483-7. PubMed ID: 12972524
[TBL] [Abstract][Full Text] [Related]
15. 18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients.
Paulus P; Sambon A; Vivegnis D; Hustinx R; Moreau P; Collignon J; Deneufbourg JM; Rigo P
Laryngoscope; 1998 Oct; 108(10):1578-83. PubMed ID: 9778305
[TBL] [Abstract][Full Text] [Related]
16. Geometric analysis of loco-regional recurrences in relation to pre-treatment hypoxia in patients with head and neck cancer.
Boeke S; Thorwarth D; Mönnich D; Pfannenberg C; Reischl G; La Fougère C; Nikolaou K; Mauz PS; Paulsen F; Zips D; Welz S
Acta Oncol; 2017 Nov; 56(11):1571-1576. PubMed ID: 28891398
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-HYNIC Annexin-V imaging of primary head and neck carcinoma.
Vermeersch H; Loose D; Lahorte C; Mervillie K; Dierckx R; Steinmetz N; Vanderheyden JL; Cuvelier C; Slegers G; Van de Wiele C
Nucl Med Commun; 2004 Mar; 25(3):259-63. PubMed ID: 15094444
[TBL] [Abstract][Full Text] [Related]
18. [18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methods.
Dresel S; Grammerstorff J; Schwenzer K; Brinkbäumer K; Schmid R; Pfluger T; Hahn K
Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):995-1003. PubMed ID: 12739070
[TBL] [Abstract][Full Text] [Related]
19. Iodine-123 alpha-methyl-l-tyrosine single-photon emission tomography for the visualization of head and neck squamous cell carcinomas.
Flamen P; Bernheim N; Deron P; Caveliers V; Chavatte K; Franken PR; Bossuyt A
Eur J Nucl Med; 1998 Feb; 25(2):177-81. PubMed ID: 9473267
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
